A lawsuit involving Medtronic’s hernia mesh products recently commenced in federal court in Boston.
In July 2026, the National Health Commission of the People’s Republic of China and two other relevant central departments jointly issued the Circular on Further Improving the Centralized Procurement of Medical Equipment in Public Medical and Health Institutions, which explicitly brought laparoscopic
On July 16, GE Healthcare announced a 10-year strategic partnership worth $500 million (approximately 3.4 billion Chinese yuan) with Catholic Health.
Long‑dominated by overseas brands that left China with no alternative, the surgical‑robot sector now sees Chinese‑made equipment powering one out of every two robotic‑assisted remote surgeries worldwide. Through over a decade‑long journey of continuous innovation, China’s surgical‑robot industry has
On July 9, 2026, the Financial Times of the UK cited people familiar with the matter as reporting that Blackstone and TPG are looking to sell Hologic’s Surgical Unit for more than $4 billion (approximately 27.2‑billion Chinese yuan) and have engaged advisors to push forward with the deal.
Recently, Nature published a groundbreaking medical study, in which an engineering and surgical team from the University of California, San Diego (UCSD) accomplished the world‑first‑ever in‑vivo surgical trial performed by a remotely operated humanoid robot.
On July 8, Johnson & Johnson officially announced that its Dual‑Energy THERMOCOOL SMARTTOUCH‑SF (DE‑ST‑SF) dual‑energy ablation platform has secured US FDA clearance for market launch. It marks the world’s first interventional device enabling seamless switching between radio‑frequency ablation (RF)
On July 7, 2026, Japanese surgical robotics company Medicaroid officially announced that its self-developed Hinotori laparoscopic surgical robot has successfully obtained the EU CE-MDR certification.
We sincerely invite global industry peers to attend the 2nd China (Global) Conference of Medical Equipment & The 10th Endoscopy Congress (CCME 2026).
The grand event will take place at Yangtze River International Conference Center, Nanjing, China from July 22 to 23, 2026.
In the first half of 2026, the commercialization of domestic surgical robots is entering a critical stage of accelerated rollout.
According to an announcement from Jiejing Medical, the company’s single-use electronic upper and lower gastrointestinal imaging catheters have successfully passed review by the Liaoning Provincial Drug Administration and officially obtained Class II Medical Device Registration Certificates.
On July 2, the National Medical Products Administration (NMPA) announced that it has approved the registration application for the innovative intracranial stent developed by Sino-Keno Medical Technology (Shanghai) Co., Ltd.
On July 1, Terumo Corporation, Japan’s leading medical device manufacturer, released a global recall notice to launch a simultaneous voluntary recall across all its worldwide distribution regions for specific models of its Relay™Pro Thoracic Stent-Graft System. This product, designed for endovascul
Suzhou Wushuang Medical's Silu® Implantable Cardiac Monitor (ICM) was officially approved by China's NMPA on July 1, 2026, marking the first domestically developed ICM product in China. This breakthrough fills a long-standing gap in the domestic ICM field and represents a critical milest
This article covers Neuralink’s groundbreaking transdural brain-computer interface (BCI) surgery unveiled on July 1, 2026.
The dura mater, a tough natural protective membrane covering the brain, used to be partially cut open in all traditional invasive BCI implantations, bringing high risks of infe
To boost the globalization of China’s medical device industry, the "Domestic Medical Device Overseas Product Promotion Conference" will be held alongside CCME 2026—the 2nd Global Medical Device Innovation Conference & 10th Endoscopy Conference.
SmartIQ is specifically designed to address the trade-off between image quality and radiation dose levels in coronary imaging procedures.
The rollout will allow Ardent's care teams to view patient imaging information in one system.
Stryker Corporation announced today that it has completed the acquisition of Amplitude Vascular Systems (AVS). The transaction amount was not disclosed .
In the USA and China, 30% of severe symptomatic aortic stenosis patients are inoperable. This is due to other health risks or old age. For inoperable patients, minimally invasive valve repair or replacement via a transcatheter approach is recommended.
Diagens' reach now extends to over 400 medical institutions across China, including adoption by 40% of the nation's top ten hospitals.
Both organisations plan to use Olympus' network and EndoRobotics' expertise to make the solutions globally available.
The Stealth AXiS platform supports customisable adoption based on each hospital’s needs.
Avatar's software translates CT and MR imaging data into 3D images to streamline surgical planning and operating room workflows.
Ultreon 3.0 uses AI and OCT to provide real-time, high-resolution imaging during minimally invasive heart procedures.
New data on the pulsed-field ablation (PFA) device class debuts at HRS 2026 as the field catches the eye of several large medtech companies.
Should the transaction complete, J&J will inherit Atraverse's radiofrequency system for simplifying access to the heart's left atrium.
UT Austin researchers developed a dual-light 3D printing method using resin that creates objects with both soft and hard properties, promising advances in prosthetics and medical devices that better interface with the human body.
The company, whose shares climbed nearly 8% Wednesday morning, also said a recent cyber incident has been contained and did not significantly affect first-quarter results.
The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high blood pressure, according to the study's authors.
